Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining As CFO/CBO To Lead U.S. Site
MUNICH--(BUSINESS WIRE)--Isarna Therapeutics GmbH, a leader in TGF-ß therapeutics, today announced that it has raised Euro 5.5 million (US$ 7.6 million) in equity from its current investors including AT NewTec, Global Asset Funds, and MIG Fonds. The company also announced that Elizabeth Czerepak has joined Isarna’s management team as Chief Financial Officer and Chief Business Officer to lead the company’s new office location in New York City.
Help employers find you! Check out all the jobs and post your resume.